董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Alan Muney | 男 | Director | 69 | 37.69万美元 | 未持股 | 2023-04-30 |
| Kim M. Rivera | 女 | Director | 54 | 未披露 | 未持股 | 2023-04-30 |
| Marlow Hernandez | 男 | Chief Executive Officer,Director | 38 | 432.00万美元 | 未持股 | 2023-04-30 |
| Angel Morales | 男 | Director | 49 | 37.69万美元 | 未持股 | 2023-04-30 |
| Solomon D. Trujillo | 男 | Director and Chairman of the Board | 71 | 44.62万美元 | 未持股 | 2023-04-30 |
| Jacqueline Guichelaar | 女 | Director | 50 | 37.69万美元 | 未持股 | 2023-04-30 |
| Kim M. Rivera | 女 | Director | 54 | 37.69万美元 | 未持股 | 2023-04-30 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Marlow Hernandez | 男 | Chief Executive Officer,Director | 38 | 432.00万美元 | 未持股 | 2023-04-30 |
| Brian D. Koppy | 男 | Chief Financial Officer | 53 | 142.99万美元 | 未持股 | 2023-04-30 |
| Robert Camerlinck | 男 | Chief Operating Officer | 56 | 370.37万美元 | 未持股 | 2023-04-30 |
| Richard B. Aguilar | 男 | Chief Clinical Officer | 66 | 136.38万美元 | 未持股 | 2023-04-30 |
| David Armstrong | 男 | General Counsel, Chief Compliance Officer and Secretary | 58 | 104.06万美元 | 未持股 | 2023-04-30 |
| Mark Novell | 男 | Chief Accounting Officer | 60 | 未披露 | 未持股 | 2023-04-30 |
董事简历
中英对照 | 中文 | 英文- Alan Muney
-
艾伦穆尼是Alan M. Muney咨询公司的创始人和首席执行官，该公司成立于2020年1月。Muney先生于2011年10月至2018年12月担任管理医疗保健和保险公司信诺公司（纽约证券交易所代码：CI）的首席医疗官，并于2017年2月至2018年12月担任全面健康和网络执行副总裁。自2022年3月起，穆尼博士还是SelectQuote公司（纽约证券交易所代码：SLQT）的顾问委员会成员。Muney博士于2010年3月加入信诺公司，担任全面健康和网络高级副总裁。穆尼博士曾在2007年至2010年担任另类投资管理公司黑石公司（纽约证券交易所代码：BX）的运营团队执行董事，以及黑石旗下的Equity Healthcare部门的创始人和首席执行官，该部门负责管理黑石投资组合公司的福利和医疗成本。穆尼博士还自2022年4月起担任Curewell Capital的高级顾问，自2019年10月起担任贝恩公司的外部顾问，自2018年8月起担任New Enterprise Associates的高级顾问，于2018年1月至2022年5月期间担任Pritzker Private Capital的高级顾问，并于2010年4月至2021年4月期间担任Arsenal Capital Partners的高级顾问。穆尼博士在布朗大学获得生物学学士学位和医学学位，在拉凡纳大学获得卫生管理硕士学位。
Alan Muney,is the founder and CEO of Alan M. Muney Advisory, LLC, which was formed in January 2020. Mr. Muney served as Chief Medical Officer of Cigna Corp. (NYSE: CI), a managed healthcare and insurance company, from October 2011 to December 2018, and as Executive Vice President of Total Health and Network from February 2017 to December 2018. Dr. Muney is also a member of the advisory board at SelectQuote, Inc. (NYSE: SLQT) since March 2022. Dr. Muney joined Cigna Corp. in March 2010 as Senior Vice President of Total Health and Network. Dr. Muney served as an executive director in the operations group at Blackstone Inc. (NYSE: BX), an alternative investment management company from 2007 to 2010, as well as the founder and Chief Executive Officer of Equity Healthcare, a division inside Blackstone that manages benefits and medical costs for Blackstone's portfolio companies. Dr. Muney has also served as Senior Advisor at Curewell Capital since April 2022, as External Advisor at Bain & Company since October 2019, as Senior Advisor at New Enterprise Associates since August 2018, as Senior Advisor at Pritzker Private Capital between January 2018 and May 2022 and as Senior Advisor at Arsenal Capital Partners between April 2010 and April 2021. Dr. Muney received a BS in biology and a medical degree from Brown University, and a Masters in health administration from the University of La Verne. - 艾伦穆尼是Alan M. Muney咨询公司的创始人和首席执行官，该公司成立于2020年1月。Muney先生于2011年10月至2018年12月担任管理医疗保健和保险公司信诺公司（纽约证券交易所代码：CI）的首席医疗官，并于2017年2月至2018年12月担任全面健康和网络执行副总裁。自2022年3月起，穆尼博士还是SelectQuote公司（纽约证券交易所代码：SLQT）的顾问委员会成员。Muney博士于2010年3月加入信诺公司，担任全面健康和网络高级副总裁。穆尼博士曾在2007年至2010年担任另类投资管理公司黑石公司（纽约证券交易所代码：BX）的运营团队执行董事，以及黑石旗下的Equity Healthcare部门的创始人和首席执行官，该部门负责管理黑石投资组合公司的福利和医疗成本。穆尼博士还自2022年4月起担任Curewell Capital的高级顾问，自2019年10月起担任贝恩公司的外部顾问，自2018年8月起担任New Enterprise Associates的高级顾问，于2018年1月至2022年5月期间担任Pritzker Private Capital的高级顾问，并于2010年4月至2021年4月期间担任Arsenal Capital Partners的高级顾问。穆尼博士在布朗大学获得生物学学士学位和医学学位，在拉凡纳大学获得卫生管理硕士学位。
- Alan Muney,is the founder and CEO of Alan M. Muney Advisory, LLC, which was formed in January 2020. Mr. Muney served as Chief Medical Officer of Cigna Corp. (NYSE: CI), a managed healthcare and insurance company, from October 2011 to December 2018, and as Executive Vice President of Total Health and Network from February 2017 to December 2018. Dr. Muney is also a member of the advisory board at SelectQuote, Inc. (NYSE: SLQT) since March 2022. Dr. Muney joined Cigna Corp. in March 2010 as Senior Vice President of Total Health and Network. Dr. Muney served as an executive director in the operations group at Blackstone Inc. (NYSE: BX), an alternative investment management company from 2007 to 2010, as well as the founder and Chief Executive Officer of Equity Healthcare, a division inside Blackstone that manages benefits and medical costs for Blackstone's portfolio companies. Dr. Muney has also served as Senior Advisor at Curewell Capital since April 2022, as External Advisor at Bain & Company since October 2019, as Senior Advisor at New Enterprise Associates since August 2018, as Senior Advisor at Pritzker Private Capital between January 2018 and May 2022 and as Senior Advisor at Arsenal Capital Partners between April 2010 and April 2021. Dr. Muney received a BS in biology and a medical degree from Brown University, and a Masters in health administration from the University of La Verne.
- Kim M. Rivera
-
Kim M. Rivera，自2022年3月起担任数据隐私、安全和治理软件公司OneTrust LLC的首席法律和商务官。她曾于2021年2月至12月在跨国信息技术公司惠普公司（纽约证券交易所代码：HPQ）担任首席执行官特别顾问。从2019年1月至2021年2月，里维拉女士担任惠普战略与业务管理总裁兼首席法务官。2015年11月至2019年1月，里维拉女士在惠普担任首席法务官和公司秘书。2010年至2015年，里维拉女士担任医疗保健公司达维塔保健医疗保健伙伴公司（纽约证券交易所代码：DVA）的首席法务官和公司秘书。里维拉女士曾担任消费者和专业产品的全球制造商和营销商Clorox公司（纽约证券交易所代码：CLX）的首席合规官，以及工业自动化和信息技术公司罗克韦尔自动化公司（纽约证券交易所代码：ROK）的首席诉讼顾问。2019年，里维拉被任命为跨国媒体集团汤普森路透公司（纽约证券交易所代码：TRI）的董事会成员，在该公司的审计和风险委员会任职。里维拉女士获得了哈佛大学法学院的京东和杜克大学的学士学位。
Kim M. Rivera,has served as Chief Legal and Business Officer of OneTrust LLC, a data privacy, security and governance software company, since March 2022. She previously served as Special Advisor to the CEO at the Hewlett-Packard Company (NYSE: HPQ), a multinational information technology company, from February through December 2021. From January 2019 to February 2021, Ms. Rivera served as Hewlett-Packard's President, Strategy and Business Management and Chief Legal Officer. From November 2015 to January 2019, Ms. Rivera served as Chief Legal Officer and Corporate Secretary at Hewlett-Packard. From 2010 to 2015, Ms. Rivera served as the Chief Legal Officer and Corporate Secretary for DaVita HealthCare Partners Inc. (NYSE: DVA), a healthcare company. Previously, Ms. Rivera was the Chief Compliance Officer at the Clorox Company (NYSE: CLX), a global manufacturer and marketer of consumer and professional products, and the Chief Litigation Counsel for Rockwell Automation, Inc. (NYSE: ROK), an industrial automation and information technology company. Ms. Rivera was appointed to the board of Thompson Reuters Corporation (NYSE: TRI), a multinational media conglomerate, in 2019, where she serves on the Audit and Risk committees. Ms. Rivera received a JD from Harvard Law School and a BA from Duke University. - Kim M. Rivera，自2022年3月起担任数据隐私、安全和治理软件公司OneTrust LLC的首席法律和商务官。她曾于2021年2月至12月在跨国信息技术公司惠普公司（纽约证券交易所代码：HPQ）担任首席执行官特别顾问。从2019年1月至2021年2月，里维拉女士担任惠普战略与业务管理总裁兼首席法务官。2015年11月至2019年1月，里维拉女士在惠普担任首席法务官和公司秘书。2010年至2015年，里维拉女士担任医疗保健公司达维塔保健医疗保健伙伴公司（纽约证券交易所代码：DVA）的首席法务官和公司秘书。里维拉女士曾担任消费者和专业产品的全球制造商和营销商Clorox公司（纽约证券交易所代码：CLX）的首席合规官，以及工业自动化和信息技术公司罗克韦尔自动化公司（纽约证券交易所代码：ROK）的首席诉讼顾问。2019年，里维拉被任命为跨国媒体集团汤普森路透公司（纽约证券交易所代码：TRI）的董事会成员，在该公司的审计和风险委员会任职。里维拉女士获得了哈佛大学法学院的京东和杜克大学的学士学位。
- Kim M. Rivera,has served as Chief Legal and Business Officer of OneTrust LLC, a data privacy, security and governance software company, since March 2022. She previously served as Special Advisor to the CEO at the Hewlett-Packard Company (NYSE: HPQ), a multinational information technology company, from February through December 2021. From January 2019 to February 2021, Ms. Rivera served as Hewlett-Packard's President, Strategy and Business Management and Chief Legal Officer. From November 2015 to January 2019, Ms. Rivera served as Chief Legal Officer and Corporate Secretary at Hewlett-Packard. From 2010 to 2015, Ms. Rivera served as the Chief Legal Officer and Corporate Secretary for DaVita HealthCare Partners Inc. (NYSE: DVA), a healthcare company. Previously, Ms. Rivera was the Chief Compliance Officer at the Clorox Company (NYSE: CLX), a global manufacturer and marketer of consumer and professional products, and the Chief Litigation Counsel for Rockwell Automation, Inc. (NYSE: ROK), an industrial automation and information technology company. Ms. Rivera was appointed to the board of Thompson Reuters Corporation (NYSE: TRI), a multinational media conglomerate, in 2019, where she serves on the Audit and Risk committees. Ms. Rivera received a JD from Harvard Law School and a BA from Duke University.
- Marlow Hernandez
-
Marlow Hernandez自2009年起担任Cano Health首席执行官，并于2021年6月至2023年4月担任Cano Health, Inc.董事长。2023年4月，我们将董事会主席和首席执行官的角色分开，将董事长的角色分配给Solomon Trujillo，让Hernandez博士在继续担任董事的同时，将注意力集中在他作为首席执行官的角色上。作为古巴人，埃尔南德斯博士于1993年随家人移民到美国。他在迈阿密大学获得神经科学学士学位，在诺瓦东南大学获得医学学位，并获得工商管理和公共卫生硕士学位。此外，他还是美国内科医师学会的研究员，这是一个全国性的内科医生组织，专门从事成人的诊断、治疗和护理。
Marlow Hernandez,has served as the Chief Executive Officer of Cano Health since 2009 and as Cano Health, Inc. Chairman from June 2021 to April 2023. In April 2023, Cano Health, Inc. separated the roles of Chairman of the Board and Chief Executive Officer, assigning the role of Chairman to Solomon Trujillo to allow Dr. Hernandez to focus his attention on his role as Chief Executive Officer, while remaining a director. A native of Cuba, Dr. Hernandez immigrated to the U.S. with his family in 1993. He received a BS in neuroscience from the University of Miami and a medical degree from Nova Southeastern University, from which he also received a master's degree in business administration and public health. In addition, he is a fellow of the American College of Physicians, a national organization of internists, who specialize in the diagnosis, treatment, and care of adults. - Marlow Hernandez自2009年起担任Cano Health首席执行官，并于2021年6月至2023年4月担任Cano Health, Inc.董事长。2023年4月，我们将董事会主席和首席执行官的角色分开，将董事长的角色分配给Solomon Trujillo，让Hernandez博士在继续担任董事的同时，将注意力集中在他作为首席执行官的角色上。作为古巴人，埃尔南德斯博士于1993年随家人移民到美国。他在迈阿密大学获得神经科学学士学位，在诺瓦东南大学获得医学学位，并获得工商管理和公共卫生硕士学位。此外，他还是美国内科医师学会的研究员，这是一个全国性的内科医生组织，专门从事成人的诊断、治疗和护理。
- Marlow Hernandez,has served as the Chief Executive Officer of Cano Health since 2009 and as Cano Health, Inc. Chairman from June 2021 to April 2023. In April 2023, Cano Health, Inc. separated the roles of Chairman of the Board and Chief Executive Officer, assigning the role of Chairman to Solomon Trujillo to allow Dr. Hernandez to focus his attention on his role as Chief Executive Officer, while remaining a director. A native of Cuba, Dr. Hernandez immigrated to the U.S. with his family in 1993. He received a BS in neuroscience from the University of Miami and a medical degree from Nova Southeastern University, from which he also received a master's degree in business administration and public health. In addition, he is a fellow of the American College of Physicians, a national organization of internists, who specialize in the diagnosis, treatment, and care of adults.
- Angel Morales
-
Angel Morales，自2015年1月起担任投资公司Morales Capital Partners创始人兼首席执行官。莫拉莱斯曾于2009年1月至2011年5月担任美银美林全球私人股本公司的董事总经理和集团联席主管，该公司是美林的一个私人股本部门，与美国银行资本投资者公司合并，并曾担任North Cove Partners LLC的联合创始人和管理合伙人，North Cove Partners LLC是一家专注于大规模收购和增长资本融资的独立私人股本集团，2011年6月至2014年12月。莫拉莱斯先生还自2022年3月起担任Univista Insurance的董事会成员和审计委员会成员，自2021年2月起担任Avance Investment Management的高级顾问。他还自2016年9月起担任Comp Sci High董事会主席，自2019年7月起担任哈佛大学基金执行委员会和财务援助工作委员会成员，自2021年3月起担任NewSchools Venture Fund董事会和财务委员会成员，自2014年1月起担任西班牙裔奖学金基金董事会成员和财务委员会主席，自2019年12月起担任创见董事会成员和主席。莫拉莱斯获得了哈佛商院的MBA学位和哈佛大学的AB学位。
Angel Morales,has served as the Founder and Chief Executive Officer of Morales Capital Partners, an investment firm, since January 2015. Mr. Morales previously served as a Managing Director and the Group Co-Head of Bank of America Merrill Lynch Global Private Equity, a private equity arm of Merrill Lynch which merged with Bank of America Capital Investors, from January 2009 to May 2011 and as a co-Founder and Managing Partner of North Cove Partners LLC, an independent private equity group focused on large-scale buyouts and growth capital financings, from June 2011 to December 2014.Mr. Morales has also served as a board member and audit committee member of Univista Insurance since March 2022 and as a Senior Advisor to Avance Investment Management since February 2021. He also serves as chairman of the board of directors at Comp Sci High since September 2016, as a member of the Executive Committee and Financial Aid Working Committee and as the Vice Chair of the Executive Committee at Harvard College Fund since July 2019, as a member of the board of directors and the Finance Committee at NewSchools Venture Fund since March 2021, as a member of the board of directors and the Chair of the Finance Committee at Hispanic Scholarship Fund since January 2014 and as a member of the board of directors and the Chair of Transcend since December 2019. Mr. Morales received an MBA from Harvard Business School and an AB from Harvard University. - Angel Morales，自2015年1月起担任投资公司Morales Capital Partners创始人兼首席执行官。莫拉莱斯曾于2009年1月至2011年5月担任美银美林全球私人股本公司的董事总经理和集团联席主管，该公司是美林的一个私人股本部门，与美国银行资本投资者公司合并，并曾担任North Cove Partners LLC的联合创始人和管理合伙人，North Cove Partners LLC是一家专注于大规模收购和增长资本融资的独立私人股本集团，2011年6月至2014年12月。莫拉莱斯先生还自2022年3月起担任Univista Insurance的董事会成员和审计委员会成员，自2021年2月起担任Avance Investment Management的高级顾问。他还自2016年9月起担任Comp Sci High董事会主席，自2019年7月起担任哈佛大学基金执行委员会和财务援助工作委员会成员，自2021年3月起担任NewSchools Venture Fund董事会和财务委员会成员，自2014年1月起担任西班牙裔奖学金基金董事会成员和财务委员会主席，自2019年12月起担任创见董事会成员和主席。莫拉莱斯获得了哈佛商院的MBA学位和哈佛大学的AB学位。
- Angel Morales,has served as the Founder and Chief Executive Officer of Morales Capital Partners, an investment firm, since January 2015. Mr. Morales previously served as a Managing Director and the Group Co-Head of Bank of America Merrill Lynch Global Private Equity, a private equity arm of Merrill Lynch which merged with Bank of America Capital Investors, from January 2009 to May 2011 and as a co-Founder and Managing Partner of North Cove Partners LLC, an independent private equity group focused on large-scale buyouts and growth capital financings, from June 2011 to December 2014.Mr. Morales has also served as a board member and audit committee member of Univista Insurance since March 2022 and as a Senior Advisor to Avance Investment Management since February 2021. He also serves as chairman of the board of directors at Comp Sci High since September 2016, as a member of the Executive Committee and Financial Aid Working Committee and as the Vice Chair of the Executive Committee at Harvard College Fund since July 2019, as a member of the board of directors and the Finance Committee at NewSchools Venture Fund since March 2021, as a member of the board of directors and the Chair of the Finance Committee at Hispanic Scholarship Fund since January 2014 and as a member of the board of directors and the Chair of Transcend since December 2019. Mr. Morales received an MBA from Harvard Business School and an AB from Harvard University.
- Solomon D. Trujillo
-
Solomon D. Trujillo，他是Trujillo Group Investments, LLC的创始人，自2003年起担任董事长。自Cano Health于2021年成为上市公司以来，他被选为董事会的首席独立董事，直到他被选为Cano Health, Inc.的非执行董事长。2005年7月至2009年2月，他曾领导3家大型全球市值公司，包括担任澳大利亚媒体和电信公司Telstra Corporation Limited （ASX： TLSYY）的首席执行官和董事；2003年2月至2004年4月，担任Orange S.A.（前身为France tsamicom, S.A.) （CAC 40： ORAN）（一家跨国电信公司）的首席执行官和董事；1995年7月至1998年5月，他担任US West Communications, Inc.（纽约证券交易所上市公司）的首席执行官；1998年6月至2002年7月，他担任US West, Inc.（纽约证券交易所代码：USW）的董事长兼首席执行官。他目前担任Western Union Company（NYSE： WU）的董事会成员，这是一家跨国金融服务公司。此前，他曾担任PepsiCo（NASDAQ： PEP）、美国银行（NYSE： BAC）和Target Corporation（NYSE： TGT）等世界上最受尊敬的全球品牌公司的董事会成员。他还曾担任行业领先公司的董事会成员，包括EDS, Gannett Co.， WPP plc（纽约证券交易所代码：WPP）和Fang Holdings Limited（纽约证券交易所代码：SFUN）。他曾担任George W. Bush政府的贸易政策顾问，并积极参与与贸易、生产力、创新和经济发展有关的公共政策问题。他是New Cadence Productions（面向新主流观众的美国电视和电影内容创作工作室）的主席和创始合伙人。他还担任Bain & Company, Inc.（一家管理咨询公司）的高级顾问，并担任the Stanford Center on Longevity的顾问委员会成员。Trujillo先生是Trujillo Group, LLC的唯一成员。他还曾担任TruCo Technology, LLC的董事长兼首席执行官（2013年7月至2021年7月），Encantos的董事长（2020年9月至2022年7月），Agua Media的董事长（2021年7月至2023年1月）。Trujillo先生自2018年1月起担任L'ATTITUDE的联合创始人，自2022年8月起担任L'ATTITUDE Ventures的联合创始人，自2010年1月起担任Latino Donor Collaborative的联合创始人，这是一家致力于美国拉丁裔群体数据和研究的非营利组织，旨在突出所有美国人的增长机会和拉丁裔社区提升经济的力量。他持有the University of Wyoming的学士学位和工商管理硕士学位。
Solomon D. Trujillo,is the founder of Trujillo Group Investments, LLC, where he has served as Chairman since 2003. In April 2023, Mr. Trujillo was elected to serve as Cano Health, Inc. non-executive Chairman of the Board, and, since Cano Health becoming a public company in 2021, he was elected to serve as the Board's lead independent director until his election to serve as Cano Health, Inc. non-executive Chairman of the Board. Mr. Trujillo has previously led 3 large market-cap global companies, including as the CEO and a director of Telstra Corporation Limited (ASX: TLSYY), an Australian media and telecommunications company, from July 2005 to February 2009; as the CEO and a director of Orange S.A. (formerly France Télécom, S.A.) (CAC 40: ORAN), a multinational telecommunications corporation, from February 2003 to April 2004; and from July 1995 until May 1998, he served as the CEO of US West Communications, Inc., a NYSE listed company, and from June 1998 until July 2002 he served as Chairman and CEO of US West, Inc. (NYSE: USW). Mr. Trujillo currently serves on the board of directors of Western Union Company (NYSE: WU), a multinational financial services company. He previously served on the boards of directors of companies that are among the world's most admired global brands, including PepsiCo (NASDAQ: PEP), Bank of America (NYSE: BAC), and Target Corporation (NYSE: TGT). He has also served on the boards of industry-leading companies including EDS, Gannett Co., WPP plc (NYSE: WPP), and Fang Holdings Limited (NYSE: SFUN). Mr. Trujillo served as a trade policy advisor to both the Clinton and George W. Bush administrations and remains active in public policy issues related to trade, productivity, innovation and economic development. Mr. Trujillo is the Chairman and Founding Partner of New Cadence Productions, a U.S. television and film content creation studio for the New Mainstream audience. He also serves as a Senior Advisor for Bain & Company, Inc., a management consulting company and serves on the board of advisors at the Stanford Center on Longevity. Mr. Trujillo is the sole member of Trujillo Group, LLC. He has also served as the Chairman and CEO of TruCo Technology, LLC from July 2013 until July 2021, the Chairman of Encantos from September 2020 until July 2022, and the Chairman of Agua Media from July 2021 until January 2023. Mr. Trujillo is the co-founder of L'ATTITUDE since January 2018, L'ATTITUDE Ventures since August 2022 and Latino Donor Collaborative, a non-profit organization dedicated to data and research regarding the US Latino cohort designed to highlight growth opportunities for all Americans and the Latino community's power to uplift the economy, since January 2010. Mr. Trujillo received his BS and MBA from the University of Wyoming. - Solomon D. Trujillo，他是Trujillo Group Investments, LLC的创始人，自2003年起担任董事长。自Cano Health于2021年成为上市公司以来，他被选为董事会的首席独立董事，直到他被选为Cano Health, Inc.的非执行董事长。2005年7月至2009年2月，他曾领导3家大型全球市值公司，包括担任澳大利亚媒体和电信公司Telstra Corporation Limited （ASX： TLSYY）的首席执行官和董事；2003年2月至2004年4月，担任Orange S.A.（前身为France tsamicom, S.A.) （CAC 40： ORAN）（一家跨国电信公司）的首席执行官和董事；1995年7月至1998年5月，他担任US West Communications, Inc.（纽约证券交易所上市公司）的首席执行官；1998年6月至2002年7月，他担任US West, Inc.（纽约证券交易所代码：USW）的董事长兼首席执行官。他目前担任Western Union Company（NYSE： WU）的董事会成员，这是一家跨国金融服务公司。此前，他曾担任PepsiCo（NASDAQ： PEP）、美国银行（NYSE： BAC）和Target Corporation（NYSE： TGT）等世界上最受尊敬的全球品牌公司的董事会成员。他还曾担任行业领先公司的董事会成员，包括EDS, Gannett Co.， WPP plc（纽约证券交易所代码：WPP）和Fang Holdings Limited（纽约证券交易所代码：SFUN）。他曾担任George W. Bush政府的贸易政策顾问，并积极参与与贸易、生产力、创新和经济发展有关的公共政策问题。他是New Cadence Productions（面向新主流观众的美国电视和电影内容创作工作室）的主席和创始合伙人。他还担任Bain & Company, Inc.（一家管理咨询公司）的高级顾问，并担任the Stanford Center on Longevity的顾问委员会成员。Trujillo先生是Trujillo Group, LLC的唯一成员。他还曾担任TruCo Technology, LLC的董事长兼首席执行官（2013年7月至2021年7月），Encantos的董事长（2020年9月至2022年7月），Agua Media的董事长（2021年7月至2023年1月）。Trujillo先生自2018年1月起担任L'ATTITUDE的联合创始人，自2022年8月起担任L'ATTITUDE Ventures的联合创始人，自2010年1月起担任Latino Donor Collaborative的联合创始人，这是一家致力于美国拉丁裔群体数据和研究的非营利组织，旨在突出所有美国人的增长机会和拉丁裔社区提升经济的力量。他持有the University of Wyoming的学士学位和工商管理硕士学位。
- Solomon D. Trujillo,is the founder of Trujillo Group Investments, LLC, where he has served as Chairman since 2003. In April 2023, Mr. Trujillo was elected to serve as Cano Health, Inc. non-executive Chairman of the Board, and, since Cano Health becoming a public company in 2021, he was elected to serve as the Board's lead independent director until his election to serve as Cano Health, Inc. non-executive Chairman of the Board. Mr. Trujillo has previously led 3 large market-cap global companies, including as the CEO and a director of Telstra Corporation Limited (ASX: TLSYY), an Australian media and telecommunications company, from July 2005 to February 2009; as the CEO and a director of Orange S.A. (formerly France Télécom, S.A.) (CAC 40: ORAN), a multinational telecommunications corporation, from February 2003 to April 2004; and from July 1995 until May 1998, he served as the CEO of US West Communications, Inc., a NYSE listed company, and from June 1998 until July 2002 he served as Chairman and CEO of US West, Inc. (NYSE: USW). Mr. Trujillo currently serves on the board of directors of Western Union Company (NYSE: WU), a multinational financial services company. He previously served on the boards of directors of companies that are among the world's most admired global brands, including PepsiCo (NASDAQ: PEP), Bank of America (NYSE: BAC), and Target Corporation (NYSE: TGT). He has also served on the boards of industry-leading companies including EDS, Gannett Co., WPP plc (NYSE: WPP), and Fang Holdings Limited (NYSE: SFUN). Mr. Trujillo served as a trade policy advisor to both the Clinton and George W. Bush administrations and remains active in public policy issues related to trade, productivity, innovation and economic development. Mr. Trujillo is the Chairman and Founding Partner of New Cadence Productions, a U.S. television and film content creation studio for the New Mainstream audience. He also serves as a Senior Advisor for Bain & Company, Inc., a management consulting company and serves on the board of advisors at the Stanford Center on Longevity. Mr. Trujillo is the sole member of Trujillo Group, LLC. He has also served as the Chairman and CEO of TruCo Technology, LLC from July 2013 until July 2021, the Chairman of Encantos from September 2020 until July 2022, and the Chairman of Agua Media from July 2021 until January 2023. Mr. Trujillo is the co-founder of L'ATTITUDE since January 2018, L'ATTITUDE Ventures since August 2022 and Latino Donor Collaborative, a non-profit organization dedicated to data and research regarding the US Latino cohort designed to highlight growth opportunities for all Americans and the Latino community's power to uplift the economy, since January 2010. Mr. Trujillo received his BS and MBA from the University of Wyoming.
- Jacqueline Guichelaar
-
Jacqueline Guichelaar，自2019年2月起担任跨国科技公司思科公司（纳斯达克股票代码：CSCO）的集团首席信息官。她在思科的角色最近有所扩大，现在她领导着数字企业解决方案组织。Guichelaar女士曾于2017年11月至2018年10月在跨国媒体集团Thomson Reuters Corporation（纽约证券交易所代码：TRI）担任集团首席信息官。2016年2月至2017年9月，她还在金融机构劳埃德银行有限公司（纽约证券交易所代码：LYG）担任基础设施和技术服务首席信息官。此外，从2007年7月开始，她在投资银行和金融服务公司德意志银行股份公司（纽约证券交易所代码：DB）工作了12年，担任过各种职务，包括首席技术官。
Jacqueline Guichelaar,has served as the Group Chief Information Officer at Cisco Systems, Inc. (NASDAQ: CSCO), a multinational technology corporation, since February 2019. Her role at Cisco has recently expanded and she is now leading the Digital Enterprise Solutions organization. Ms. Guichelaar was previously the Group Chief Information Officer at Thomson Reuters Corporation (NYSE: TRI), a multinational media conglomerate, from November 2017 to October 2018. She also served as the Chief Information Officer Infrastructure and Technology Services at Lloyds Banking Group plc (NYSE: LYG), a financial institution, from February 2016 to September 2017. In addition, she held various roles including Chief Technology Officer during her 12-year tenure at Deutsche Bank AG (NYSE: DB), an investment bank and financial services company, beginning in July 2007. - Jacqueline Guichelaar，自2019年2月起担任跨国科技公司思科公司（纳斯达克股票代码：CSCO）的集团首席信息官。她在思科的角色最近有所扩大，现在她领导着数字企业解决方案组织。Guichelaar女士曾于2017年11月至2018年10月在跨国媒体集团Thomson Reuters Corporation（纽约证券交易所代码：TRI）担任集团首席信息官。2016年2月至2017年9月，她还在金融机构劳埃德银行有限公司（纽约证券交易所代码：LYG）担任基础设施和技术服务首席信息官。此外，从2007年7月开始，她在投资银行和金融服务公司德意志银行股份公司（纽约证券交易所代码：DB）工作了12年，担任过各种职务，包括首席技术官。
- Jacqueline Guichelaar,has served as the Group Chief Information Officer at Cisco Systems, Inc. (NASDAQ: CSCO), a multinational technology corporation, since February 2019. Her role at Cisco has recently expanded and she is now leading the Digital Enterprise Solutions organization. Ms. Guichelaar was previously the Group Chief Information Officer at Thomson Reuters Corporation (NYSE: TRI), a multinational media conglomerate, from November 2017 to October 2018. She also served as the Chief Information Officer Infrastructure and Technology Services at Lloyds Banking Group plc (NYSE: LYG), a financial institution, from February 2016 to September 2017. In addition, she held various roles including Chief Technology Officer during her 12-year tenure at Deutsche Bank AG (NYSE: DB), an investment bank and financial services company, beginning in July 2007.
- Kim M. Rivera
-
Kim M. Rivera，2011年7月成为法律总监和秘书，此前他自2010年1月起担任副总裁、总法律顾问和秘书。2006年2月至2009年11月期间担任The Clorox Company（一家消费品公司）副总裁和副总法律顾问。2004年8月至2006年2月期间，她曾担任Rockwell Automation, Inc.（工业自动化控制和信息方案供应商）副总裁和首席诉讼顾问。1999年11月至2004年8月期间，她曾担任Rockwell自动化控制和信息集团总法律顾问。在加入Rockwell之前，她曾在法律公司Jones Day担任律师。
Kim M. Rivera has been President, Strategy and Business Management and Chief Legal Officer at HP Inc. since January 2019. As President, Strategy and Business Management, she leads corporate strategy and development, customer support, indirect procurement, real estate and workplace functions. In addition, Ms. Rivera manages HP Inc.’s worldwide legal organization, including all aspects of legal and governmental affairs, brand security, compliance and ethics. She served as Chief Legal Officer and General Counsel of HP Inc. from November 2015 to January 2019. Prior to joining HP Inc., Ms. Rivera was the Chief Legal Officer and Corporate Secretary for DaVita HealthCare Partners where she was employed from 2010 to 2015. Prior to that, she served as the Chief Compliance Officer and Head of International Legal Services at The Clorox Company; Chief Litigation Counsel for Rockwell Automation, as well as General Counsel for its Automation Controls and Information Group. She has a bachelor’s degree from Duke University and a Juris Doctor degree from Harvard Law School. Ms. Rivera resides in Woodside, California. - Kim M. Rivera，2011年7月成为法律总监和秘书，此前他自2010年1月起担任副总裁、总法律顾问和秘书。2006年2月至2009年11月期间担任The Clorox Company（一家消费品公司）副总裁和副总法律顾问。2004年8月至2006年2月期间，她曾担任Rockwell Automation, Inc.（工业自动化控制和信息方案供应商）副总裁和首席诉讼顾问。1999年11月至2004年8月期间，她曾担任Rockwell自动化控制和信息集团总法律顾问。在加入Rockwell之前，她曾在法律公司Jones Day担任律师。
- Kim M. Rivera has been President, Strategy and Business Management and Chief Legal Officer at HP Inc. since January 2019. As President, Strategy and Business Management, she leads corporate strategy and development, customer support, indirect procurement, real estate and workplace functions. In addition, Ms. Rivera manages HP Inc.’s worldwide legal organization, including all aspects of legal and governmental affairs, brand security, compliance and ethics. She served as Chief Legal Officer and General Counsel of HP Inc. from November 2015 to January 2019. Prior to joining HP Inc., Ms. Rivera was the Chief Legal Officer and Corporate Secretary for DaVita HealthCare Partners where she was employed from 2010 to 2015. Prior to that, she served as the Chief Compliance Officer and Head of International Legal Services at The Clorox Company; Chief Litigation Counsel for Rockwell Automation, as well as General Counsel for its Automation Controls and Information Group. She has a bachelor’s degree from Duke University and a Juris Doctor degree from Harvard Law School. Ms. Rivera resides in Woodside, California.
高管简历
中英对照 | 中文 | 英文- Marlow Hernandez
Marlow Hernandez自2009年起担任Cano Health首席执行官，并于2021年6月至2023年4月担任Cano Health, Inc.董事长。2023年4月，我们将董事会主席和首席执行官的角色分开，将董事长的角色分配给Solomon Trujillo，让Hernandez博士在继续担任董事的同时，将注意力集中在他作为首席执行官的角色上。作为古巴人，埃尔南德斯博士于1993年随家人移民到美国。他在迈阿密大学获得神经科学学士学位，在诺瓦东南大学获得医学学位，并获得工商管理和公共卫生硕士学位。此外，他还是美国内科医师学会的研究员，这是一个全国性的内科医生组织，专门从事成人的诊断、治疗和护理。
Marlow Hernandez,has served as the Chief Executive Officer of Cano Health since 2009 and as Cano Health, Inc. Chairman from June 2021 to April 2023. In April 2023, Cano Health, Inc. separated the roles of Chairman of the Board and Chief Executive Officer, assigning the role of Chairman to Solomon Trujillo to allow Dr. Hernandez to focus his attention on his role as Chief Executive Officer, while remaining a director. A native of Cuba, Dr. Hernandez immigrated to the U.S. with his family in 1993. He received a BS in neuroscience from the University of Miami and a medical degree from Nova Southeastern University, from which he also received a master's degree in business administration and public health. In addition, he is a fellow of the American College of Physicians, a national organization of internists, who specialize in the diagnosis, treatment, and care of adults.- Marlow Hernandez自2009年起担任Cano Health首席执行官，并于2021年6月至2023年4月担任Cano Health, Inc.董事长。2023年4月，我们将董事会主席和首席执行官的角色分开，将董事长的角色分配给Solomon Trujillo，让Hernandez博士在继续担任董事的同时，将注意力集中在他作为首席执行官的角色上。作为古巴人，埃尔南德斯博士于1993年随家人移民到美国。他在迈阿密大学获得神经科学学士学位，在诺瓦东南大学获得医学学位，并获得工商管理和公共卫生硕士学位。此外，他还是美国内科医师学会的研究员，这是一个全国性的内科医生组织，专门从事成人的诊断、治疗和护理。
- Marlow Hernandez,has served as the Chief Executive Officer of Cano Health since 2009 and as Cano Health, Inc. Chairman from June 2021 to April 2023. In April 2023, Cano Health, Inc. separated the roles of Chairman of the Board and Chief Executive Officer, assigning the role of Chairman to Solomon Trujillo to allow Dr. Hernandez to focus his attention on his role as Chief Executive Officer, while remaining a director. A native of Cuba, Dr. Hernandez immigrated to the U.S. with his family in 1993. He received a BS in neuroscience from the University of Miami and a medical degree from Nova Southeastern University, from which he also received a master's degree in business administration and public health. In addition, he is a fellow of the American College of Physicians, a national organization of internists, who specialize in the diagnosis, treatment, and care of adults.
- Brian D. Koppy
Brian D. Koppy，自2021年4月起担任公司首席财务官。在加入Cano Health之前，Koppy先生于2019年4月至2021年3月担任医疗保健公司西维斯健康公司（纽约证券交易所代码：CVS）的企业财务规划和分析高级副总裁。在CVS与安泰保险金融集团合并之前，Koppy先生于2013年6月至2019年3月担任安泰商业市场业务首席财务官。Koppy先生还曾在艾斯兰公司（纽约证券交易所代码：AIZ）和巴恩斯公司（纽约证券交易所代码：B）任职。科皮在康涅狄格大学获得了金融学学士和MBA学位。
Brian D. Koppy,has served as the Company's Chief Financial Officer since April 2021. Prior to joining Cano Health, Mr. Koppy served as Senior Vice President of Enterprise Financial Planning and Analysis for CVS Health Corporation (NYSE: CVS), a healthcare company, from April 2019 to March 2021. Prior to CVS' merger with Aetna Inc., Mr. Koppy served as Chief Financial Officer of Aetna's Commercial Markets Business from June 2013 to March 2019. Mr. Koppy also has prior experience at Assurant, Inc. (NYSE: AIZ), and Barnes Group, Inc. (NYSE: B). Mr. Koppy received a BS and an MBA in finance from the University of Connecticut.- Brian D. Koppy，自2021年4月起担任公司首席财务官。在加入Cano Health之前，Koppy先生于2019年4月至2021年3月担任医疗保健公司西维斯健康公司（纽约证券交易所代码：CVS）的企业财务规划和分析高级副总裁。在CVS与安泰保险金融集团合并之前，Koppy先生于2013年6月至2019年3月担任安泰商业市场业务首席财务官。Koppy先生还曾在艾斯兰公司（纽约证券交易所代码：AIZ）和巴恩斯公司（纽约证券交易所代码：B）任职。科皮在康涅狄格大学获得了金融学学士和MBA学位。
- Brian D. Koppy,has served as the Company's Chief Financial Officer since April 2021. Prior to joining Cano Health, Mr. Koppy served as Senior Vice President of Enterprise Financial Planning and Analysis for CVS Health Corporation (NYSE: CVS), a healthcare company, from April 2019 to March 2021. Prior to CVS' merger with Aetna Inc., Mr. Koppy served as Chief Financial Officer of Aetna's Commercial Markets Business from June 2013 to March 2019. Mr. Koppy also has prior experience at Assurant, Inc. (NYSE: AIZ), and Barnes Group, Inc. (NYSE: B). Mr. Koppy received a BS and an MBA in finance from the University of Connecticut.
- Robert Camerlinck
Robert Camerlinck，自2022年8月起担任公司首席运营官。在这一任命之前，从2020年6月起，Camerlinck先生担任Healthy Partners，Inc.的总裁。Healthy Partners，Inc.是他于1994年创立的一家初级保健服务提供商，该公司于2020年6月收购了该公司。2000年至2020年5月，Camerlinck先生担任Healthy Partners，Inc.的首席执行官。
Robert Camerlinck,has served as the Company's Chief Operating Officer since August 2022. Prior to such appointment, from June 2020 Mr. Camerlinck served as President of Healthy Partners, Inc., a provider of primary care services that he founded in 1994, which the Company acquired in June 2020. From 2000 to May 2020, Mr. Camerlinck served as Healthy Partners, Inc.'s Chief Executive Officer.- Robert Camerlinck，自2022年8月起担任公司首席运营官。在这一任命之前，从2020年6月起，Camerlinck先生担任Healthy Partners，Inc.的总裁。Healthy Partners，Inc.是他于1994年创立的一家初级保健服务提供商，该公司于2020年6月收购了该公司。2000年至2020年5月，Camerlinck先生担任Healthy Partners，Inc.的首席执行官。
- Robert Camerlinck,has served as the Company's Chief Operating Officer since August 2022. Prior to such appointment, from June 2020 Mr. Camerlinck served as President of Healthy Partners, Inc., a provider of primary care services that he founded in 1994, which the Company acquired in June 2020. From 2000 to May 2020, Mr. Camerlinck served as Healthy Partners, Inc.'s Chief Executive Officer.
- Richard B. Aguilar
Richard B. Aguilar，自2015年起担任公司首席临床官。阿吉拉尔博士是美国内科医师学会、国家西语裔医学协会和美国糖尿病协会的成员。从1988年到2021年，阿吉拉尔博士在加利福尼亚州唐尼和亨廷顿公园开设了一家私人诊所。阿吉拉尔博士曾于1990年至1992年担任多家医院的医务长和重症监护室主任，并于2006年至2010年担任俄勒冈州本德High Lakes Health Care的糖尿病护理主任。Aguilar博士还在2003年至2006年期间担任美国糖尿病协会和拉丁裔医疗保健提供者CE规划委员会的顾问委员会成员。2009年，Aguilar博士获得了美国糖尿病协会/国家质量保证委员会的认可，成为俄勒冈州糖尿病医师认可计划的获得者，2011年，他在加州的办公室获得了同样的患者护理奖。2017年和2018年，位于迈阿密的多家Cano Health办事处也获得了这一认可。阿吉拉尔博士也是糖尿病国家的联合创始人和医疗主任，这是一个初级保健组织，公布了糖尿病干预和管理与卓越计划护理模型的结果。Aguilar博士在加州大学欧文分校医学院获得医学学位，并在加州大学欧文分校医学中心和长滩退伍军人管理局医疗中心完成了实习和内科住院医师实习。
Richard B. Aguilar,has served as the Company's Chief Clinical Officer since 2015. Dr. Aguilar is a member of the American College of Physicians, National Hispanic Medical Association, as well as the American Diabetic Association. Dr. Aguilar maintained a private practice with offices in Downey and Huntington Park, CA from 1988 to 2021. Dr. Aguilar has served as Chief of Medicine and Chief of the ICU at several hospitals from 1990 to 1992 and from 2006 to 2010 was also director of Diabetes Care for High Lakes Health Care in Bend, Oregon. Dr. Aguilar also served as an advisory board member to the American Diabetes Association and the Latino Health Care Provider CE Planning Committee from 2003 to 2006. In 2009, Dr. Aguilar was recognized by the American Diabetes Association/National Committee for Quality Assurance as a recipient of the Diabetes Physician Recognition Program in the state of Oregon and in 2011, he received the same award for patient care at his California offices. In 2017 and again in 2018, various Miami-based Cano Health offices also received this recognition. Dr. Aguilar also is co-founder and Medical Director of Diabetes Nation, a primary care founded group which published its Diabetes Intervention and Management with Excellence Program Care Model results. Dr. Aguilar received his medical degree at the University of California, Irvine College of Medicine and completed his internship and residency in Internal Medicine at UC Irvine Medical Center and Long Beach Veterans Administration Medical Center.- Richard B. Aguilar，自2015年起担任公司首席临床官。阿吉拉尔博士是美国内科医师学会、国家西语裔医学协会和美国糖尿病协会的成员。从1988年到2021年，阿吉拉尔博士在加利福尼亚州唐尼和亨廷顿公园开设了一家私人诊所。阿吉拉尔博士曾于1990年至1992年担任多家医院的医务长和重症监护室主任，并于2006年至2010年担任俄勒冈州本德High Lakes Health Care的糖尿病护理主任。Aguilar博士还在2003年至2006年期间担任美国糖尿病协会和拉丁裔医疗保健提供者CE规划委员会的顾问委员会成员。2009年，Aguilar博士获得了美国糖尿病协会/国家质量保证委员会的认可，成为俄勒冈州糖尿病医师认可计划的获得者，2011年，他在加州的办公室获得了同样的患者护理奖。2017年和2018年，位于迈阿密的多家Cano Health办事处也获得了这一认可。阿吉拉尔博士也是糖尿病国家的联合创始人和医疗主任，这是一个初级保健组织，公布了糖尿病干预和管理与卓越计划护理模型的结果。Aguilar博士在加州大学欧文分校医学院获得医学学位，并在加州大学欧文分校医学中心和长滩退伍军人管理局医疗中心完成了实习和内科住院医师实习。
- Richard B. Aguilar,has served as the Company's Chief Clinical Officer since 2015. Dr. Aguilar is a member of the American College of Physicians, National Hispanic Medical Association, as well as the American Diabetic Association. Dr. Aguilar maintained a private practice with offices in Downey and Huntington Park, CA from 1988 to 2021. Dr. Aguilar has served as Chief of Medicine and Chief of the ICU at several hospitals from 1990 to 1992 and from 2006 to 2010 was also director of Diabetes Care for High Lakes Health Care in Bend, Oregon. Dr. Aguilar also served as an advisory board member to the American Diabetes Association and the Latino Health Care Provider CE Planning Committee from 2003 to 2006. In 2009, Dr. Aguilar was recognized by the American Diabetes Association/National Committee for Quality Assurance as a recipient of the Diabetes Physician Recognition Program in the state of Oregon and in 2011, he received the same award for patient care at his California offices. In 2017 and again in 2018, various Miami-based Cano Health offices also received this recognition. Dr. Aguilar also is co-founder and Medical Director of Diabetes Nation, a primary care founded group which published its Diabetes Intervention and Management with Excellence Program Care Model results. Dr. Aguilar received his medical degree at the University of California, Irvine College of Medicine and completed his internship and residency in Internal Medicine at UC Irvine Medical Center and Long Beach Veterans Administration Medical Center.
- David Armstrong
David Armstrong，自2018年8月起担任公司总法律顾问和首席合规官。在加入Cano Health之前，Armstrong先生曾担任多个公司职务，包括2008年5月至2017年12月担任医疗保健服务提供商Promise Healthcare，Inc.的总法律顾问、首席合规官和公司秘书；为综合管理式医疗联盟Kaiser Permanente担任大西洋中部各州的高级法律顾问；以及Blue Cross Blue Shield Association的独立持牌人、密歇根州BlueCross BlueShield的助理总法律顾问。此外，Armstrong先生还在私人执业领域从事法律工作，最近于2017年12月至2018年8月在宾夕法尼亚州Julie Allison律师事务所担任合伙人，这是一家提供全方位服务的律师事务所，其全国客户包括企业家、医院、诊所、设施、临床实验室、医生、医疗集团、保险经纪人和医疗保健提供者网络。Armstrong先生在密歇根大学法学院获得京东（优等生）学位，在密歇根州立大学获得本科学位。阿姆斯特朗是佛罗里达州、马里兰州、宾夕法尼亚州和密歇根州的律师协会会员。
David Armstrong,has served as the Company's General Counsel and Chief Compliance Officer since August 2018. Prior to joining Cano Health, Mr. Armstrong served in a number of corporate roles including General Counsel, Chief Compliance Officer and Corporate Secretary of Promise Healthcare, Inc., a healthcare service provider, from May 2008 to December 2017; Senior Counsel Mid-Atlantic States for Kaiser Permanente, an integrated managed care consortium; and Assistant General Counsel at BlueCross BlueShield of Michigan, an independent licensee of Blue Cross Blue Shield Association. In addition, Mr. Armstrong has practiced law in private practice, most recently as partner in the Law Offices of Julie Allison, P.A. from December 2017 to August 2018, a full-service law firm with a national clientele of clients including entrepreneurs,hospitals, clinics, facilities, clinical laboratories, physicians, medical groups, insurance brokers and healthcare provider networks. Mr. Armstrong earned his JD (cum laude) from the University of Michigan Law School and his undergraduate degree from Michigan State University. Mr. Armstrong is a member of the Bar in Florida, Maryland, Pennsylvania and Michigan.- David Armstrong，自2018年8月起担任公司总法律顾问和首席合规官。在加入Cano Health之前，Armstrong先生曾担任多个公司职务，包括2008年5月至2017年12月担任医疗保健服务提供商Promise Healthcare，Inc.的总法律顾问、首席合规官和公司秘书；为综合管理式医疗联盟Kaiser Permanente担任大西洋中部各州的高级法律顾问；以及Blue Cross Blue Shield Association的独立持牌人、密歇根州BlueCross BlueShield的助理总法律顾问。此外，Armstrong先生还在私人执业领域从事法律工作，最近于2017年12月至2018年8月在宾夕法尼亚州Julie Allison律师事务所担任合伙人，这是一家提供全方位服务的律师事务所，其全国客户包括企业家、医院、诊所、设施、临床实验室、医生、医疗集团、保险经纪人和医疗保健提供者网络。Armstrong先生在密歇根大学法学院获得京东（优等生）学位，在密歇根州立大学获得本科学位。阿姆斯特朗是佛罗里达州、马里兰州、宾夕法尼亚州和密歇根州的律师协会会员。
- David Armstrong,has served as the Company's General Counsel and Chief Compliance Officer since August 2018. Prior to joining Cano Health, Mr. Armstrong served in a number of corporate roles including General Counsel, Chief Compliance Officer and Corporate Secretary of Promise Healthcare, Inc., a healthcare service provider, from May 2008 to December 2017; Senior Counsel Mid-Atlantic States for Kaiser Permanente, an integrated managed care consortium; and Assistant General Counsel at BlueCross BlueShield of Michigan, an independent licensee of Blue Cross Blue Shield Association. In addition, Mr. Armstrong has practiced law in private practice, most recently as partner in the Law Offices of Julie Allison, P.A. from December 2017 to August 2018, a full-service law firm with a national clientele of clients including entrepreneurs,hospitals, clinics, facilities, clinical laboratories, physicians, medical groups, insurance brokers and healthcare provider networks. Mr. Armstrong earned his JD (cum laude) from the University of Michigan Law School and his undergraduate degree from Michigan State University. Mr. Armstrong is a member of the Bar in Florida, Maryland, Pennsylvania and Michigan.
- Mark Novell
Mark Novell，自2021年5月起担任公司首席会计官。在加入Cano Health之前，Novell先生曾于2016年10月至2021年2月担任主要连锁脱毛沙龙European Wax Center公司（纳斯达克股票代码：EWCZ）的首席会计官和副总裁兼财务总监，负责财务报告、财务管理、税务合规和结构设计以及财务系统。他曾于1999年6月至2016年10月担任嘉年华邮轮公司 & PLC（纽约证券交易所/伦敦证券交易所代码：CCL；纽约证券交易所代码：CUK）副总裁兼助理公司财务总监，在嘉年华增长最迅速的时期负责全球报告和会计事务。诺维尔在宾夕法尼亚州立大学获得会计学学士学位。
Mark Novell,has served as the Company's Chief Accounting Officer since May 2021. Prior to joining Cano Health, Mr. Novell served as Chief Accounting Officer and Vice President, Controller of European Wax Center Inc. (NASDAQ: EWCZ), a major chain of hair removal salons, from October 2016 to February 2021 where he led financial reporting, treasury management, tax compliance and structuring, and financial systems. He was Vice President, Assistant Corporate Controller of Carnival Corporation & PLC (NYSE/LSE: CCL; NYSE: CUK) from June 1999 to October 2016 where he oversaw global reporting and accounting matters during Carnival's most rapid period of growth. Mr. Novell earned a BS in Accounting from Pennsylvania State University.- Mark Novell，自2021年5月起担任公司首席会计官。在加入Cano Health之前，Novell先生曾于2016年10月至2021年2月担任主要连锁脱毛沙龙European Wax Center公司（纳斯达克股票代码：EWCZ）的首席会计官和副总裁兼财务总监，负责财务报告、财务管理、税务合规和结构设计以及财务系统。他曾于1999年6月至2016年10月担任嘉年华邮轮公司 & PLC（纽约证券交易所/伦敦证券交易所代码：CCL；纽约证券交易所代码：CUK）副总裁兼助理公司财务总监，在嘉年华增长最迅速的时期负责全球报告和会计事务。诺维尔在宾夕法尼亚州立大学获得会计学学士学位。
- Mark Novell,has served as the Company's Chief Accounting Officer since May 2021. Prior to joining Cano Health, Mr. Novell served as Chief Accounting Officer and Vice President, Controller of European Wax Center Inc. (NASDAQ: EWCZ), a major chain of hair removal salons, from October 2016 to February 2021 where he led financial reporting, treasury management, tax compliance and structuring, and financial systems. He was Vice President, Assistant Corporate Controller of Carnival Corporation & PLC (NYSE/LSE: CCL; NYSE: CUK) from June 1999 to October 2016 where he oversaw global reporting and accounting matters during Carnival's most rapid period of growth. Mr. Novell earned a BS in Accounting from Pennsylvania State University.